FGF2 and endometrial carcinoma: In a study examining endometrial carcinoma stem cells (ECSCs) under both tumorsphere conditions and differentiated states—achieved by removing basic fibroblast growth factor (bFGF)—a significant decrease in SOX3 mRNA expression was observed in differentiated conditions compared to their undifferentiated tumorsphere counterparts (Figure 2A).